Lonza Group (OTCMKTS:LZAGY) Stock Rating Lowered by Zacks Research

Lonza Group (OTCMKTS:LZAGY) was downgraded by Zacks Research from a “strong-buy” rating to a “hold” rating in a research report issued on Monday,Zacks.com reports.

Lonza Group Trading Down 0.8%

Shares of LZAGY opened at $67.88 on Monday. The company has a current ratio of 1.52, a quick ratio of 1.04 and a debt-to-equity ratio of 0.45. The stock has a fifty day moving average price of $69.96 and a two-hundred day moving average price of $68.22. Lonza Group has a 52-week low of $55.57 and a 52-week high of $73.29.

Lonza Group Company Profile

Lonza Group AG, together with its subsidiaries, supplies various products and services for pharmaceutical, biotech, and nutrition markets in Europe, North and Central America, Latin America, Asia, Australia, New Zealand, and internationally. It operates through Biologics, Small Molecules, Cell & Gene, and Capsules & Health Ingredients segments.